Stock info Abbott | Filter  Basic-Info

Stock: Abbott (US broad), ISIN: US0028241000

Last Price 138.08 Max Price 138.08
Min Price 102.12 1 Year return 0.00
Sector Health Care Subsector Health Care Eq. & Services
Annual report 2017

Abbott (previously known as Abbott alkaloid Company) is well known pharmaceutical company listed in S&P 500. The company is having approximately 90,000 employees in over 130 countries. Abbott was founded in 1888 by Wallace C. Abbott and is having its headquarters in Abbott Park, a northern suburb of Chicago, Illinois.

Loading...

Contact info:Street: 100 Abbott Park RoadZip Code: IL 600646400City: Abbott ParkCountry: USAPhone: (847) 9376100Website: www.abbott.comCEO: Miles D. WhiteCFO: Thomas C. Freyman

Sector Review Abbott

Loading...
Year Turnover Total sector Market share
2019 28,460 1,913,914 1.49 %
2020 28,337 1,909,606 1.48 %
2021 37,891 2,240,566 1.69 %
2022 40,789 2,630,563 1.55 %
2023 36,343 2,750,507 1.32 %

Advice Abbott

Date Label Bank Label Stock Label Advice Label Price Label Diff Label
September 22, 2014 RBC Capital Markets Abbott Buy 48.00 -143.50 %



News Abbott

Analysts expect over 2023 revenue increase Abbott

Tomorrow Abbott will publish its past quarters results. Over the current book year the total revenu from the company based in will be 39.9 billion USD (consensus estimates). This is slightly lower than 2022's revenue of 43.65 billion USD. Historical revenues...

Analysts: more sales Abbott

Tomorrow the American Abbott will publish its past quarters figures. For this year Abbott 's revenue will be around 39.96 billion USD. This is according to the average of the analysts' estimates. This is rather significant more than 2021's revenue of 34.61 billion...

Analysts expect revenue increase Abbott

Tomorrow Abbott will publish it's past quarters results. For this year the company, based in Abbott Park revenue will be around 39.29 billion USD. This is according to the average of the analysts' estimates. This is quite more than 2021's revenue of 34.61 billion...

Analysts expect revenue increase Abbott

Tomorrow Abbott will publish its past quarters results. Over the current book year the total revenue from the company in Abbott Park will be 39.29 billion USD (consensus estimates). This is quite more than 2020's revenue of 34.61 billion USD. Historical revenues...

Analysts expect over 2021 rising revenue Abbott

Tomorrow the American company Abbott will publish its past quarter results. Over the current book year the company from Abbott Park's total revenue could be around 42.2 billion USD (consensus estimates). This is hugely more than 2020's revenue of 34.61 billion...

Annual reports Abbott

2017 2018 2019 2020 2021

Profile Abbott

Abbott

(US0028241000)/ ABT

The headquarter of Abbott is based in Abbott Park. The core activities of Abbott are in the pharmaceutical sector. Miles D. White manages the company as a CEO. Thomas C. Freyman runs the company as a CFO. The past 10 years the (international) industry gained at around 75 percent. Measured since 2011 the sector is 147 percent higher and over the past 12 months (December 2015-2016) there is a minus of 75 percent.

The past year was a profitable year Abbott investors

The period between December 2015 and December 2016 was a bad period for the investors. The stock lost almost 13 percent. Abbott' stock rose the past 5 years at around 44 percent. Abbott's revenues between 2011 and 2015 were far from constant and moved between 39,87 billion dollars and 20,41 billion dollars. The net results between 2011 and 2015 were far from constant and fluctuated between 4,73 billion dollars and 2,61 billion dollars.

The American company paid out dividends in the past 5 years. Over the past 5 years Abbott's dividend yield was at around 6,11 percent per year. Over the past 5 years the company raised it's dividends each year. Because of the yearly increased dividends Abbott can be called a kind of dividend aristocrat.

Abbott financed with relatively low debt

At the end of 2015 the American company had a balance sheet of 41,25 billion dollars. 20,04 billion dollars (48,58 percent of the total balance sheet) was financed by debt. Last year the pharmaceutical company's price/earnings-ratio (PE) was around 25. So the investors valued the stock at 25 times 2015' earnings per share. Based on the classical stock valuation theories the American stock can be seen as a value stock.

At the end of 2015 the market capitalization (the number of shares outstanding multiplied by the stock price) of the pharmaceutical company equaled around 63,56 billion dollars. At the end of 2015 around 1,47 billion stocks were listed.

All Abbott's financial reports are available here. More information about Abbott can be found it's website. .


Results Abbott

Results
2015
2016
2017
2018
2019
2020
Revenue
18,789
19,835
22,832
26,661
28,460
28,337
Costs
14,717
18,504
22,435
24,597
25,171
24,657
Profit
4,072
1,331
397
2,064
3,289
3,680
Margin of profit
21.67
6.71
1.74
7.74
11.56
12.99
ROI
20.85
6.81
1.54
7.76
11.86
13.71

Balance Abbott

Balance
2015
2016
2017
2018
2019
2020
Equity
19,531
19,535
25,756
26,614
27,732
26,843
Debt
18,449
30,560
37,806
31,955
32,827
32,559
Total assets
37,980
50,095
63,562
58,569
60,559
59,402
Solvency
51.42
39.00
40.52
45.44
45.79
45.19
Cash
5,639
17,858
8,010
3,562
3,693
5,852
Cashflow
2,731
3,046
4,643
5,493
5,473
6,469
Employees
0
0
0
0
0
Revenue per employee
0.0
0.0
0.0
0.0
0.0
Cashflow / Debt
0.15
0.10
0.12
0.17
0.17
0.20

Details Abbott

Details
2016
2017
2018
2019
2020
Price
44.91
38.41
57.07
72.33
86.86
Eps
0.0
0.0
1.00
1.00
2.00
Price/earnings-ratio
0.0
0.0
57.07
72.33
69.04
Dividend
0.0
0.0
0.0
1.00
1.00
Dividend %
0.00 %
0.00 %
0.00 %
1.38 %
0.72 %
Payout %
0.0
0.0
0.0
1.00
0.50
Book value
13.26
14.77
15.16
15.73
15.16
Market to book
0.30
0.38
0.27
0.22
0.11
Cashflow per stock
2.07
2.66
3.13
3.11
3.65
Stocks
1,473
1,744
1,756
1,763
1,771
Market Cap
66.146.56
66.971.77
100.193.23
127.481.63
244.571.44

Dividend Abbott


Price info Abbott

Date
Price
25 Jun 2025
138.08
20 Jun 2025
132.41
07 Jun 2025
133.58
03 Jun 2025
133.57
28 May 2025
132.94
27 May 2025
131.30
19 May 2025
134.80
09 May 2025
134.00
01 May 2025
130.75
29 Apr 2025
129.53
22 Apr 2025
129.89
09 Apr 2025
124.86
08 Apr 2025
124.86
03 Apr 2025
131.93
30 Mar 2025
130.82
27 Mar 2025
126.61
26 Mar 2025
125.60
20 Mar 2025
127.42
15 Mar 2025
126.71
12 Mar 2025
132.66
01 Mar 2025
138.01
25 Feb 2025
134.95
23 Feb 2025
134.92
18 Feb 2025
130.61
13 Feb 2025
130.49
12 Feb 2025
131.44
07 Feb 2025
129.07
05 Feb 2025
129.10
02 Feb 2025
127.93
21 Jan 2025
113.48